Heron Therapeutics, Inc. 2026 Q1 - Results - Earnings Call Presentation
Heron Therapeutics, Inc. reported its Q1 2026 earnings results, revealing a loss and a decline in revenue compared to the previous year. The company's earnings per share (EPS) was -$0.04, which fell short of expectations by $0.02. Additionally, revenue for the quarter was $34.71 million, a decrease of 10.78% year-over-year, missing projections by $2.01 million.
- ▪Heron Therapeutics, Inc. reported an EPS of -$0.04 for Q1 2026.
- ▪The company's revenue for the quarter was $34.71 million, down 10.78% year-over-year.
- ▪The revenue missed expectations by $2.01 million.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4905714-heron-therapeutics-inc-2026-q1-results-earnings-call-presentation"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
